Showing results (2361-2370 of 2,391) with videos related to
Sort By:
Pageof 240
Eclinicalmedicine|April 24, 2023
The implications of defining obesity as a disease: a report from the Association for the Study of Obesity 2021 annual conferenceMigena Luli, Giles Yeo, Emma Farrell, et al.Cell Stem Cell|August 4, 2023
Tff2 defines transit-amplifying pancreatic acinar progenitors that lack regenerative potential and are protective against Kras-driven carcinogenesisZhengyu Jiang, Feijing Wu, Pasquale Laise, et al.Nature Metabolism|October 7, 2025
Effect of sweeteners and sweetness enhancers on weight management and gut microbiota composition in individuals with overweight or obesity: the SWEET studyMichelle D Pang, Louise Kjølbæk, Jacco J A J Bastings, et al.Nature Medicine|October 23, 2023
CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trialAndreas Mackensen, John B A G Haanen, Christian Koenecke, et al.Journal of Medicinal Chemistry|June 30, 2012
(1R,2R)-N-(1-cyanocyclopropyl)-2-(6-methoxy-1,3,4,5-tetrahydropyrido[4,3-b]indole-2-carbonyl)cyclohexanecarboxamide (AZD4996): a potent and highly selective cathepsin K inhibitor for the treatment of osteoarthritisAlexander G Dossetter, Howard Beeley, Jonathan Bowyer, et al.Journal of the Endocrine Society|January 10, 2019
Baseline Characteristics of Infants With Atypical Genital Development: Phenotypes, Diagnoses, and Sex of RearingCourtney Finlayson, Ilina Rosoklija, Christopher E Aston, et al.The Science of the Total Environment|November 28, 2021
Cross-continental importance of CH4 emissions from dry inland-watersJosé R Paranaíba, Ralf Aben, Nathan Barros, et al.Nature|December 10, 2025
The influence of short-lived halogens on atmospheric chemistry and climateAlfonso Saiz-Lopez, Anoop S Mahajan, Jonathan Abbatt, et al.Science Immunology|November 15, 2022
Exposure to BA.4/5 S protein drives neutralization of Omicron BA.1, BA.2, BA.2.12.1, and BA.4/5 in vaccine-experienced humans and miceAlexander Muik, Bonny Gaby Lui, Maren Bacher, et al.Nature Medicine|February 17, 2009
Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cellsRonald T Mitsuyasu, Thomas C Merigan, Andrew Carr, et al.Pageof 240